Reporting owner · CIK 0001873879

FitzPatrick Margaret M

Visual SEC Form 4 history across 1 companies, 1 transactions and 1 filings.

DIRAN2 Therapeutics, Inc.
Open-market mix
Filings1Form 4 records
Buying$11.6K1 purchases
Selling$00 sales
Net value$11.6KBuys minus sells
Companies11 securities
Most recentSep 01, 2026buy

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Average return0.0%Across 1 open-market buy
Median return0.0%Half the buys outperformed this
How it's computed

For every open-market buy (Form 4 code P, acquisition A) in the selected window, we take the closing price on the transaction date and 90 calendar days later, then compute the percentage change. The figures shown are the simple average and median of those per-buy returns.

  • Window follows the rest of the summary (all-history or last 3 months).
  • Only buys with a resolved price context are counted.
  • Includes both positive and negative outcomes; gains and losses net out at the per-buy level.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
530-3-51Sep 26

Net value flow

Buys minus sells

Sep 26
$11.6K

Transaction texture

Ownership and ticket size

Average P/S size$11.6K
Median P/S size$11.6K
Direct1
Indirect0
Sep 01, 2026buy

Filing-only signals

Deterministic matches in this insider's history

No filing-only signal badges matched this history.

Latest Form 4 facts

Quick context from source filings

Latest transaction

buy at AN2 Therapeutics, Inc. on Sep 01, 2026 valued at $11,602.

Review SEC filing
Latest buy

buy at AN2 Therapeutics, Inc. on Sep 01, 2026 valued at $11,602.

Review SEC filing
Latest sale

No open-market insider sale is available.

Associated companies

Visual map of known reporting history

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
ANTXFitzPatrick Margaret M
DIR
buy2.09k$1.16MP0.0%09/0209/01

FitzPatrick Margaret M Insider Activity FAQ

SEC Form 4 context

Who is FitzPatrick Margaret M?

FitzPatrick Margaret M is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001873879.

Which companies has FitzPatrick Margaret M reported transactions for?

AN2 Therapeutics, Inc.

When was FitzPatrick Margaret M's latest insider buy?

buy at AN2 Therapeutics, Inc. on Sep 01, 2026 valued at $11,602.

When was FitzPatrick Margaret M's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.